Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 61, Issue 5, 1996, Pages 1470-1476

  Harpole Jr , David H ^a,b   Richards, William G ^a   Herndon II, James E ^a   Sugarbaker, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; CANCER STAGING; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030005871     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00104-X     Document Type: Conference Paper

References (20)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA 1994;44:7-26.
2. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(Suppl):225S-33S.
3. Harpole DH, Herndon JE, Young WG, Wolfe WG, Sabiston DC. Stage I non-small cell lung cancer: a multivariate analysis of treatment and patterns of recurrence. Cancer 1995;76:787-96.
4. Macchairini P, Fontanini G, Hardin MJ, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0M0 non-small cell lung cancer. J Thorac Cardiovasc Surg 1993;106:80-8.
5. Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TMN staging system a predominant prognostic factor in pathologic stage I non-small cell lung cancer? J Thorac Cardiovasc Surg 1993;106:90-4.
6. Thomas PA, Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Ann Thorac Surg 1990;49: 242-7.
7. Takise A, Kodama T, Shimosato Y, Watanabe S, Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the lung periphery less than 2 cm diameter. Cancer 1988;61:2083-8.
8. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984;38:331-6.
9. Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT, Sugarbaker DJ. Molecular and pathologic analysis of stage I non-small cell lung carcinoma of the lung. J Clin Oncol 1995;13:1265-79.
10. Harpole DH, Herndon JE, Wolfe WG, Iglehart JD, Marks JR. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presenting symptoms, histopathology and oncoprotein staining. Cancer Res 1995; 55:51-6.
11. Harpole DH, Marks JR, Richards WG, Herndon JE, Sugar-baker DJ. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients. Clin Cancer Res 1995;1:659-64.
12. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
13. Pence JC, Kerns BM, Dodge RK, Iglehart JD. Prognostic significance of the proliferation index in surgically-resected non-small cell lung cancer. Arch Surg 1993;128:1382-90.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
16. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-200.
17. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
18. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
19. neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990;50:5184-91.
20. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 proteins correlates with a poor prognosis in human lung cancer. Cancer Res 1992;54: 4828-31.